MedC Biopharma Corporation Launches $3M Private Placement Offering

Skin oncology medication manufacturer MedC Biopharma Corp. is launching its $3 million private placement offering.
The company known for various products with cannabinoid and other natural ingredients launched the private placement via the DealSquare platform, which is supported by NEO and DealMaker technology.
DealSquare is an automated platform that enables capital raisers to release their private placement offers, and investors to electronically enter a deal. NEO is a group of fintech companies that offer capital markets infrastructure, and DealMaker grants the back-office …

Full story available on Benzinga.com

More MedC Biopharma Corporation Launches $3M Private Placement Offering